ClinicalTrials.govpublic full text
RN1201 Injection in Newly Diagnosed High-Risk Cytogenetic Multiple Myeloma
newly diagnosed high-risk cytogenetic multiple myeloma patients ineligible or unwilling to undergo asct, newly diagnosed multiple myeloma (ndmm), newly diagnosed, high-risk cytogenetic, multiple myeloma, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 903447
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.